Cargando…

Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III

AIM: The urinary glucose tetrasaccharide, Glcα1‐6Glcα1‐4Glcα1‐4Glc (Glc(4)), is a glycogen limit dextrin that is elevated in patients with glycogen storage disease (GSD) type III. We evaluated the potential of uncooked cornstarch therapy to interfere with Glc(4) monitoring, by measuring the diurnal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Sarah P., Khan, Aleena, Stefanescu, Ela, Seifts, Andrea M., Hijazi, Ghada, Austin, Stephanie, Kishnani, Priya S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932871/ https://www.ncbi.nlm.nih.gov/pubmed/33728245 http://dx.doi.org/10.1002/jmd2.12181

Ejemplares similares

The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases
por: Heiner-Fokkema, M. Rebecca, et al.
Publicado: (2020)

A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III
por: Hijazi, Ghada, et al.
Publicado: (2021)

Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV
por: Yi, Haiqing, et al.
Publicado: (2016)

Characterization of a canine model of glycogen storage disease type IIIa
por: Yi, Haiqing, et al.
Publicado: (2012)

Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?
por: El-Gharbawy, Areeg, et al.
Publicado: (2022)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort
por: Piraud, Monique, et al.
Publicado: (2020)

"Bull’s eye” appearance of hepatocellular adenomas in patients with glycogen storage disease type I — atypical magnetic resonance imaging findings: Two case reports
por: Vernuccio, Federica, et al.
Publicado: (2021)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Factors Altering Pyruvate Excretion in a Glycogen Storage Mutant of the Cyanobacterium, Synechococcus PCC7942
por: Benson, Phoebe J., et al.
Publicado: (2016)

A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
por: Lim, Jeong-A, et al.
Publicado: (2020)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Quantitative whole‐body magnetic resonance imaging in children with Pompe disease: Clinical tools to evaluate severity of muscle disease
por: Fernandes, Samuela A., et al.
Publicado: (2020)

French recommendations for the management of glycogen storage disease type III
por: Wicker, Camille, et al.
Publicado: (2023)

Regioselective Chemoenzymatic Synthesis of Ganglioside Disialyl Tetrasaccharide Epitopes
por: Meng, Xin, et al.
Publicado: (2014)

Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
por: Zhou, Xiang, et al.
Publicado: (2022)

The Interaction between Chondroitin Sulfate and Dermatan Sulfate Tetrasaccharides and Pleiotrophin
por: García-Jiménez, María Jose, et al.
Publicado: (2022)

Experience with the Urinary Tetrasaccharide Metabolite for Pompe Disease in the Diagnostic Laboratory
por: Saville, Jennifer T., et al.
Publicado: (2021)

Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice
por: Pagliarani, Serena, et al.
Publicado: (2018)

Glycogen storage disease type III: modified Atkins diet improves myopathy
por: Mayorandan, Sebene, et al.
Publicado: (2014)

Use of waxy maize heat modified starch in the treatment of children between 2 and 5 years with glycogen storage disease type I: A retrospective study
por: Hijazi, Ghada, et al.
Publicado: (2019)

Synthesis of a Systematic 64‐Membered Heparan Sulfate Tetrasaccharide Library
por: Baryal, Kedar N., et al.
Publicado: (2022)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome
por: Sentner, Christiaan P., et al.
Publicado: (2016)

PSUN249 Starvation Ketoacidosis as the Presenting Finding of Glycogen Storage Disorder Type III
por: Fiacco, Nicholas, et al.
Publicado: (2022)

Behavioral, social and school functioning in children with Pompe disease
por: Korlimarla, Aditi, et al.
Publicado: (2020)

Synthesis of Two Tetrasaccharide Pentenyl Glycosides Related to the Pectic Rhamnogalacturonan I Polysaccharide
por: Zakharova, Alexandra N., et al.
Publicado: (2018)

Construction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery System
por: Ma, Yingcong, et al.
Publicado: (2018)

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia
por: Jones, Christopher M., et al.
Publicado: (2016)

Arterial Stiffness and Central Hemodynamics are Associated with Low Diurnal Urinary Sodium Excretion
por: Del Giorno, Rosaria, et al.
Publicado: (2020)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease
por: Taylor, Kristin M., et al.
Publicado: (2013)

ON THE DIFFERING APPEARANCE OF INTRANUCLEAR AND CYTOPLASMIC GLYCOGEN IN LIVER CELLS IN GLYCOGEN STORAGE DISEASE
por: Sheldon, H., et al.
Publicado: (1962)

Convergent synthesis of the tetrasaccharide repeating unit of the O-antigen of Shigella boydii type 9
por: Santra, Abhishek, et al.
Publicado: (2011)

Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence
por: Ahmed, Tahir, et al.
Publicado: (2012)

Glass transition temperature of dried lens tissue pretreated with trehalose, maltose, or cyclic tetrasaccharide
por: Kawata, Tetsuhiro, et al.
Publicado: (2014)

Synthetic avenues towards a tetrasaccharide related to Streptococcus pneumonia of serotype 6A
por: Chaudhury, Aritra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5eq9md50n6mijieaebd4d5bjrb